Idarubicin plus Cytosine-Arabinoside (ALL R-87 Protocol) in Advanced Acute Lymphoblastic Leukemia: The GIMEMA/AIEOP Experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Idarubicin plus Cytosine-Arabinoside (ALL R-87 Protocol) in Advanced Acute Lymphoblastic Leukemia: The GIMEMA/AIEOP Experience

Published:1992-01 Issue:sup2 Volume:7 Page:15-18
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Giona Fiorina,Testi Anna Maria,Moleti Maria Luisa,Annino Luciana,Meloni Giovanna,Arcese William,Rolla Matilde,Madon Enrico,Specchia Giorgina,Rotoli Bruno,Ladogana Saverio,Zanesco Luigi,Rondelli Roberto,Pession Andrea,Mandelli Franco

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428199209058646

Reference2 articles.

1. P7: Lung cancer and head/neck tumours

2. GIMEMA ALL 0183: a multicentric study on adult acute Iymphoblastic lecukaemia in Italy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Lymphocytic Leukemia in Adults;Abeloff's Clinical Oncology;2008

2. TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission;Bone Marrow Transplantation;2000-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP